journal article Jun 01, 2008

P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: Distribution and prognostic relevance

European Journal of Cancer Vol. 44 No. 9 pp. 1217-1222 · Elsevier BV
View at Publisher Save 10.1016/j.ejca.2008.03.002
Topics

No keywords indexed for this article. Browse by subject →

References
33
[1]
Capurso "Probiotics and the incidence of colorectal cancer: when evidence is not evident" Dig Liver Dis (2006) 10.1016/s1590-8658(07)60010-3
[2]
Järvinen "Colorectal carcinoma before 40 years of age: prognosis and predisposing condition" Scand J Gastroenterol (1984) 10.1080/00365521.1984.12005784
[3]
O’Connell "Rates of colon and rectal cancers are increasing in young adults" Am Surg (2003) 10.1177/000313480306901010
[4]
Parramore "Colorectal cancer in patients under forty: presentation and outcome" Am Surg (1998)
[5]
Leff "Colorectal cancer in the young patient" Am Surg (2007) 10.1177/000313480707300110
[6]
Taylor "Prognostic factors in colorectal carcinoma of young adults" Can J Surg (1998)
[7]
Howard "Colon and rectal cancer in the young adult" Am Surg (1975)
[8]
Lee "Colorectal cancer in young patients: characteristics and outcome" Am Surg (1994)
[9]
Isbister "Large-bowel cancer in the young: a national survival study" Dis Colon Rectum (1990) 10.1007/bf02156258
[10]
Moore "Adenocarcinoma of the colon and rectum in patients less than 40 years of age" Am Surg (1984)
[11]
Keswani "Colorectal cancer in patient s younger than 40 years of age" Am Surg (2002) 10.1177/000313480206801007
[12]
Lyall "Profiling markers of prognosis in colorectal cancer" Clin Cancer Res (2006) 10.1158/1078-0432.ccr-05-1864
[13]
Krajewska "Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers" Clin Cancer Res (2005) 10.1158/1078-0432.ccr-05-0094
[14]
Buglioni "Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2" Int J Cancer (1999) 10.1002/(sici)1097-0215(19991222)84:6<545::aid-ijc1>3.0.co;2-2
[15]
Silvestrini "Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience" Br J Cancer (1993) 10.1038/bjc.1993.191
[16]
D’Agnano "DNA ploidy, cell kinetics, epidermal growth factor rceptor and HER-2/neu oncoprotein epression in primary operablebreast cancer" Ann N Y Acad Sci (1996) 10.1111/j.1749-6632.1996.tb16266.x
[17]
Martin "Colorectal carcinoma in patients less than 40 years of age: pathology and prognosis" Dis Colon Rectum (1981) 10.1007/bf02603445
[18]
Green "Mucinous carcinoma–just another colon cancer?" Dis Colon Rctum (1993) 10.1007/bf02050301
[19]
Goi "Clinicopathological study of the colorectal mucinous carcinomas" Int Surg (2006)
[20]
Cascinu "S-phase fraction and tumor aneuploidy in colorectal carcinoma of young patients" Cancer (1996) 10.1002/(sici)1097-0142(19961101)78:9<1857::aid-cncr3>3.0.co;2-c
[21]
Buglioni "p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy" Anatomic Pathology (2001)
[22]
Munro "P53 abnormalities and outcome in colorectal cancer: a sistematic review" Br J Cancer (2005) 10.1038/sj.bjc.6602358
[23]
Lan "P53 protein accumulation as a prognostic marker in sporadic colorectal cancer" Int J Colorectal Dis (2007) 10.1007/s00384-006-0194-6
[24]
Liang "Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age" Br J Surg (2003) 10.1002/bjs.4015
[25]
Locker "ASCO 2006 update of recommendation for the use of tumor markers in astrointestinal cancer" J Clin Oncol (2006) 10.1200/jco.2006.08.2644
[26]
Westra "Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease free survival in adjuvant treated stage III colon cancer patients" J Clin Oncol (2005) 10.1200/jco.2005.04.096
[27]
Ofner "Immunohistochemically detectable Bcl-2 expression in colorectal carcinoma: correlation with tumor stage and patient survival" Brit J Cancer (1995) 10.1038/bjc.1995.446
[28]
Han "Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer" J Gastroenterol Hepatol (2006) 10.1111/j.1440-1746.2006.04325.x
[29]
Blagosklonny "Paradox of Bcl-2 (and p53): why may apoptosis-regulating proteins be irrelevant to cell death?" BioEssay (2001) 10.1002/bies.1135
[30]
Liang "P53 overexpression predicts poor chemosensitivity to high-dose fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancer after palliative bowel resection" Int J Cancer (2002) 10.1002/ijc.1637
[31]
Bunz "Disruption of p53 in human cancer cells alters the response to therapeutic agents" J Clin Invest (1999) 10.1172/jci6863
[32]
Watson "Evidence that the p53 negative/ Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients" World J Surg Oncol (2005) 10.1186/1477-7819-3-47
[33]
Resnick "Epidermal growth factor receptor, c-MET, beta catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study" Clin Cancer Res (2004) 10.1158/1078-0432.ccr-03-0462
Metrics
26
Citations
33
References
Details
Published
Jun 01, 2008
Vol/Issue
44(9)
Pages
1217-1222
License
View
Cite This Article
A. Torsello, C. Garufi, M. Cosimelli, et al. (2008). P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: Distribution and prognostic relevance. European Journal of Cancer, 44(9), 1217-1222. https://doi.org/10.1016/j.ejca.2008.03.002